Growth Metrics

Canton Strategic Holdings (CNTN) Cash from Financing Activities (2021 - 2026)

Canton Strategic Holdings posted quarterly Cash from Financing Activities of $87.0 million for Q1 2026, up 42200.79% year-on-year from N/an in Q1 2025, and down 10.76% on a QoQ basis from $97.4 million in Q4 2025.

Canton Strategic Holdings (CNTN) has 6 years of Cash from Financing Activities data on file, last reported at $87.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Financing Activities rose 42200.79% year-over-year to $87.0 million; the trailing twelve-month figure through Mar 2026 stood at $193.9 million (up 5579.56% YoY), and the FY2025 full-year result was $107.2 million, up 2939.54% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at $87.0 million, down from $97.4 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $97.4 million in Q4 2025 and bottomed at -$338585.0 in Q3 2022.
  • The 5-year median for Cash from Financing Activities is $1.6 million (2024), against an average of $13.1 million.
  • The widest annual swing landed in 2022, when Cash from Financing Activities tumbled 485.1%; it then surged 42200.79% in 2026.
  • A 5-year view of Cash from Financing Activities shows it stood at -$193457.0 in 2022, then soared by 5094.25% to $9.7 million in 2023, then sank by 81.18% to $1.8 million in 2024, then jumped by 5257.28% to $97.4 million in 2025, then slipped by 10.76% to $87.0 million in 2026.
  • The last three Cash from Financing Activities figures came in at $87.0 million (Q1 2026), $97.4 million (Q4 2025), and $7.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 7.00 Mn
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -600,000.00
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 53,000.00
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn -538.80 Mn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -802.20 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 15.71 Mn
10 Canton Strategic Holdings 643.89 Mn 602.36 Mn - 86.96 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 86.96 Mn
Mar 31, 2026 86.96 Mn
Dec 31, 2025 97.44 Mn
Dec 31, 2025 97.44 Mn
Sep 30, 2025 7.22 Mn
Sep 30, 2025 7.22 Mn
Jun 30, 2025 2.31 Mn
Jun 30, 2025 2.31 Mn
Mar 31, 2025 205,568.00
Mar 31, 2025 205,568.00
Dec 31, 2024 1.82 Mn
Dec 31, 2024 1.82 Mn
Sep 30, 2024 -257,730.00
Sep 30, 2024 -257,730.00
Jun 30, 2024 1.65 Mn
Jun 30, 2024 1.65 Mn
Mar 31, 2024 317,119.00
Mar 31, 2024 317,119.00
Dec 31, 2023 9.66 Mn
Dec 31, 2023 9.66 Mn
Sep 30, 2023 -306,006.00
Sep 30, 2023 -306,006.00
Jun 30, 2023 1.85 Mn
Jun 30, 2023 1.85 Mn
Mar 31, 2023 523,364.00
Mar 31, 2023 523,364.00
Dec 31, 2022 -193,457.00
Dec 31, 2022 -193,457.00
Sep 30, 2022 -338,585.00
Sep 30, 2022 -338,585.00
Jun 30, 2022 -264,288.00
Jun 30, 2022 -264,288.00
Mar 31, 2022 13.86 Mn
Mar 31, 2022 13.86 Mn
Dec 31, 2021 -33,064.00
Dec 31, 2021 -33,064.00
Sep 30, 2021 332,600.00
Sep 30, 2021 332,600.00
Jun 30, 2021 276,187.00
Jun 30, 2021 276,187.00
Mar 31, 2021 323,025.00
Mar 31, 2021 323,025.00